Literature DB >> 10235009

Surgical techniques for arteriovenous malformations in functional areas: focus on the superior temporal gyrus.

S Yamada1, F Brauer, L Dayes, S Yamada1.   

Abstract

Direct surgical intervention of arteriorvenous malformations (AVMs) in functional areas has been accepted as a standard mode of treatment. However, safe and successful intervention requires that such factors as exact location, size, vascular supply, and drainage be considered. Importantly, surgical techniques must be individualized to each patient, based on hemodynamic anatomy of the AVM. This paper discusses AVMs in the superior temporal lobe, which have a complex neuronal anatomy and circulatory system; the authors present 22 patients with AVMs of various sizes and describe the surgical techniques specific for the indicated location. Surgical procedures adhered to the following principles: 1) avoid brain tissue removal; 2) preserve microcirculation; 3) maintain circulation of the isolated major draining vein to access the AVM core; 4) compartmental isolation; and 5) preservation of functional area cortex covering the AVM. All patients underwent total resection except one, who had a subtotal resection. Neurological and occupational recovery was remarkable except for partial hemianesthesia in one patient; two patients are still in rehabilitation. This is the first description of a direct surgical approach to AVMs in the superior temporal gyrus, where management is challenging because the lesions may extend elsewhere, such as to Broca's and Wernicke's areas. The results suggest that the procedure is promising.

Entities:  

Mesh:

Year:  1998        PMID: 10235009     DOI: 10.2176/nmc.38.suppl_222

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  1 in total

1.  Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes.

Authors:  Andreu Gabarrós Canals; Ana Rodríguez-Hernández; William L Young; Michael T Lawton
Journal:  J Neurosurg       Date:  2013-07-12       Impact factor: 5.115

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.